Stryker (SYK) cash: $4B
Stryker held $4B in cash and cash equivalents on Dec 31, 2025, up 9.8% from $3.7B a year earlier.
From Stryker's filings with the SEC · Read the filing · SYK stock page
Stryker cash by year
#158 of 4,171 US companies by cash · See the full ranking
| Year ended | Cash | Change |
|---|---|---|
| Dec 31, 2025 | $4B | +10% |
| Dec 31, 2024 | $3.7B | +23% |
| Dec 31, 2023 | $3B | +61% |
| Dec 31, 2022 | $1.8B | -37% |
| Dec 31, 2021 | $2.9B | – |
Cash of similar companies
Companies in the same industry as Stryker, by SEC industry code, with the closest cash. Each name opens the same page for that company.
| Company | Cash, latest year | Year ended |
|---|---|---|
| 3M | $5.2B | Dec 31, 2025 |
| Stryker | $4B | Dec 31, 2025 |
| Baxter International | $2B | Dec 31, 2025 |
| Boston Scientific | $2B | Dec 31, 2025 |
| Medline | $1.9B | Dec 31, 2025 |
| Resmed | $1.4B | Dec 31, 2025 |
| Dexcom | $918M | Dec 31, 2025 |
Questions and answers
What is Stryker's cash?
Stryker held $4B in cash and cash equivalents on Dec 31, 2025, up 9.8% from $3.7B a year earlier.
Numbers as reported in Stryker's annual and quarterly reports to the SEC (XBRL data). A year is the company's fiscal year that falls mostly in that calendar year; balances such as cash and debt are as of the date shown. Data only, not investment advice. Methodology